Director, Global Portfolio Strategy – Shionogi Inc. (U.S.) – Jobs in Florham Park, NJ | OpenJobs AI

Which company is this position for?

Shionogi Inc. (U.S.)

Job Details

Overview Company

Director, Global Portfolio Strategy

$215k/y-$245k/y

Shionogi Inc. (U.S.)

2 days ago

Highlight

OnsiteFull-timeDirector

Summary

Shionogi Inc. (U.S.) is seeking a Director, Global Portfolio Strategy to join their team in Florham Park, NJ. The role involves leading strategic planning initiatives for early-stage projects and optimizing portfolio analysis processes.

About the Role

As the Director of Global Portfolio Strategy, you will develop commercial assessments for pipeline assets, facilitate project team discussions, manage market research initiatives, and build collaborative relationships with internal stakeholders. You will also analyze portfolio data, assess performance, and provide insights to senior management while monitoring changes in the pharmaceutical industry.

About You

Required:

10 years of relevant experience, including 5 years in pharmaceutical Portfolio Management, New Product Planning, or Strategic Planning roles.
Bachelor's degree in Life Sciences, Finance, or related field; MBA preferred.
Experience in pharmaceutical forecasting and strong understanding of corporate finance principles.

Preferred:

Prior experience in strategy consulting.
Experience working in global, matrixed environments.
Experience with portfolio management analytical tools (e.g., Planview).

Benefits

Competitive base salary ranging from $215k to $245k.
Comprehensive benefits package including health insurance and retirement plans.

Shionogi Inc. (U.S.)

Since 1878, we have been committed to developing new treatments to improve patients' lives worldwide. We are helping to address global health challenges such as antimicrobial resistance and COVID-19. Since the 1950s, we have discovered and introduced several novel antibiotics, as well as innovative medications for HIV and influenza. Today, we are developing an investigational oral antiviral for COVID-19 and advancing clinical programs in Fragile X syndrome, acute ischemic stroke as well metabolic disorders and oncology. Our team is driven to impact patient lives. Our partnerships with industry, government agencies, biotech companies and academia help to advance science with the urgency that today's health challenges demand. Through a combination of in-house discovery and strategic partnerships, we continue to deliver firsts for patients in the U.S. and worldwide. See our community guidelines: https://bit.ly/4n3Jhe4

Florham Park, NJ